Cite
HARVARD Citation
Younossi, Z. et al. (2016). Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet gastroenterology and hepatology. pp. 122-132. [Online].